Skip to content
healthcare.dev

AKUTUR

NDC 59469-301, BENZOIC ACID, NITRIC ACID, Apis mellifera, Lytta vesicatoria, Populus tremuloides Bark, ANEMONE PRATENSIS Flowering TOP, GINGER, and Solidago virgaurea Flowering Top, solution/ drops, from PEKANA Nautrheilmittel GmbH.

Product NDC
59469-301
Status
Listed
Labeler
PEKANA Nautrheilmittel GmbH
Dosage form
SOLUTION/ DROPS
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59469-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZOIC ACID4 [hp_X]/50mL
  • NITRIC ACID6 [hp_X]/50mL
  • APIS MELLIFERA3 [hp_X]/50mL
  • LYTTA VESICATORIA4 [hp_X]/50mL
  • POPULUS TREMULOIDES BARK2 [hp_X]/50mL
  • PULSATILLA PRATENSIS FLOWERING TOP4 [hp_X]/50mL
  • GINGER3 [hp_X]/50mL
  • SOLIDAGO VIRGAUREA FLOWERING TOP2208 mg/50mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Nitrogen Binding Agent [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Standardized Insect Venom Allergenic Extract [EPC]

Package NDCNDC-11Package
59469-301-10594690301101 BOTTLE, GLASS in 1 BOX (59469-301-10) / 50 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 59469-301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59469-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59469-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.